These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29425039)

  • 21. Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.
    Sato T; Kienlen-Campard P; Ahmed M; Liu W; Li H; Elliott JI; Aimoto S; Constantinescu SN; Octave JN; Smith SO
    Biochemistry; 2006 May; 45(17):5503-16. PubMed ID: 16634632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aß40 displays amyloidogenic properties in the non-transgenic mouse brain but does not exacerbate Aß42 toxicity in Drosophila.
    De Mena L; Smith MA; Martin J; Dunton KL; Ceballos-Diaz C; Jansen-West KR; Cruz PE; Dillon KD; Rincon-Limas DE; Golde TE; Moore BD; Levites Y
    Alzheimers Res Ther; 2020 Oct; 12(1):132. PubMed ID: 33069251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms.
    Coskuner O; Wise-Scira O; Perry G; Kitahara T
    ACS Chem Neurosci; 2013 Feb; 4(2):310-20. PubMed ID: 23421682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils.
    Gu L; Guo Z
    J Neurochem; 2013 Aug; 126(3):305-11. PubMed ID: 23406382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and γ-secretase processing of the C99 peptide.
    Tang TC; Kienlen-Campard P; Hu Y; Perrin F; Opsomer R; Octave JN; Constantinescu SN; Smith SO
    J Biol Chem; 2019 Apr; 294(15):5854-5866. PubMed ID: 30755484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice.
    Stöhr J; Condello C; Watts JC; Bloch L; Oehler A; Nick M; DeArmond SJ; Giles K; DeGrado WF; Prusiner SB
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10329-34. PubMed ID: 24982137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissecting the Molecular Mechanisms of the Co-Aggregation of Aβ40 and Aβ42 Peptides: A REMD Simulation Study.
    Li X; Yang Z; Chen Y; Zhang S; Wei G; Zhang L
    J Phys Chem B; 2023 May; 127(18):4050-4060. PubMed ID: 37126408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ; Chen YR
    FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of alanine replacement of l17 and f19 on the aggregation and neurotoxicity of arctic-type aβ40.
    Chen YR; Huang HB; Lo CJ; Wang CC; Ho LK; Liu HT; Shiao MS; Lin TH; Chen YC
    PLoS One; 2013; 8(4):e61874. PubMed ID: 23634215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
    Wang L; Eom K; Kwon T
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42.
    Chen YR; Glabe CG
    J Biol Chem; 2006 Aug; 281(34):24414-22. PubMed ID: 16809342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence determinants of enhanced amyloidogenicity of Alzheimer A{beta}42 peptide relative to A{beta}40.
    Kim W; Hecht MH
    J Biol Chem; 2005 Oct; 280(41):35069-76. PubMed ID: 16079141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into Cerebral Amyloid Angiopathy Type 1 and Type 2 from Comparisons of the Fibrillar Assembly and Stability of the Aβ40-Iowa and Aβ40-Dutch Peptides.
    Rajpoot J; Crooks EJ; Irizarry BA; Amundson A; Van Nostrand WE; Smith SO
    Biochemistry; 2022 Jun; 61(12):1181-1198. PubMed ID: 35666749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural dynamics of the ΔE22 (Osaka) familial Alzheimer's disease-linked amyloid β-protein.
    Inayathullah M; Teplow DB
    Amyloid; 2011 Sep; 18(3):98-107. PubMed ID: 21668291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
    Dong M; Zhao W; Hu D; Ai H; Kang B
    ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific compositions of amyloid-beta peptides as the determinant of toxic beta-aggregation.
    Yoshiike Y; Chui DH; Akagi T; Tanaka N; Takashima A
    J Biol Chem; 2003 Jun; 278(26):23648-55. PubMed ID: 12716908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early synergy between Abeta42 and oxidatively damaged membranes in promoting amyloid fibril formation by Abeta40.
    Koppaka V; Paul C; Murray IV; Axelsen PH
    J Biol Chem; 2003 Sep; 278(38):36277-84. PubMed ID: 12821671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril.
    Xiao Y; Matsuda I; Inoue M; Sasahara T; Hoshi M; Ishii Y
    J Biol Chem; 2020 Jan; 295(2):458-467. PubMed ID: 31771980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for novel beta-sheet structures in Iowa mutant beta-amyloid fibrils.
    Tycko R; Sciarretta KL; Orgel JP; Meredith SC
    Biochemistry; 2009 Jul; 48(26):6072-84. PubMed ID: 19358576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties.
    Sánchez L; Madurga S; Pukala T; Vilaseca M; López-Iglesias C; Robinson CV; Giralt E; Carulla N
    J Am Chem Soc; 2011 May; 133(17):6505-8. PubMed ID: 21486030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.